Organizations
Conferences
Info & Opinion
December 3, 2008
With news about Cerebricon, Charles River, PharmaNet, OxyPharma and Stora Enso.
etrials announced quarterly earnings. The clinical trial technology suite reported a loss and net service revenues that dropped 7 percent, to $4.1 million. Positive trends included $4.9 million in new bookings. Cancellations during the quarter fell to just $200,000 vs.…
No articles available